Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: Result of the HPFEZ randomised study
- 30 September 2013
- journal article
- research article
- Published by Elsevier BV in Clinics and Research in Hepatology and Gastroenterology
- Vol. 37 (4), 416-421
- https://doi.org/10.1016/j.clinre.2012.10.002
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Optimal First-Line Therapy ofHelicobacter pyloriInfection in Year 2012Gastroenterology Research and Practice, 2012
- Treatment of Helicobacter pyloriCurrent Opinion in Gastroenterology, 2011
- Treatment of Helicobacter pylori Infection 2011Helicobacter, 2011
- A new look at anti-Helicobacter pylori therapyWorld Journal of Gastroenterology, 2011
- Helicobacter pylori treatment in the era of increasing antibiotic resistanceGut, 2010
- Evolution of Helicobacter pylori Therapy from a Meta‐analytical PerspectiveHelicobacter, 2007
- Eradication Therapy for Helicobacter pyloriGastroenterology, 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implicationsThe Lancet Infectious Diseases, 2006
- High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled studyAlimentary Pharmacology & Therapeutics, 2005